HTT

Chr 4ADAR

huntingtin

Also known as: HD, IT15, LOMARS

Huntingtin is a widely expressed protein required for normal development, though its precise cellular function remains incompletely understood. Mutations cause Huntington disease (typically adult-onset progressive neurodegeneration affecting movement, cognition, and behavior) and Lopes-Maciel-Rodan syndrome, with both autosomal dominant and autosomal recessive inheritance patterns reported. The gene is extremely intolerant to loss-of-function variants (pLI near 1.0), indicating it is essential for normal cellular function.

OMIMResearchSummary from RefSeq, OMIM, UniProt
MultiplemechanismAD/ARLOEUF 0.182 OMIM phenotypes
Clinical SummaryHTT
🧬
Gene-Disease Validity (ClinGen)
Huntington disease · ADDefinitive

Definitive — sufficient evidence for diagnostic panels

Population Constraint (gnomAD)
Highly constrained gene — heterozygous loss-of-function variants are very rare in the population (pLI 1.00). One damaged copy is likely sufficient to cause disease.
💊
Clinical Trials
12 active or recruiting trials — potential therapeutic options may be available

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

LoF intolerant — likely haploinsufficient
LoF Constraint
0.18LOEUF
pLI 1.000
Z-score 10.27
OE 0.12 (0.080.18)
Highly constrained

Highly LoF-intolerant (top ~10% of genes)

Missense Constraint
2.78Z-score
OE missense 0.81 (0.780.85)
1404 obs / 1729.3 exp
Mild constraint

Moderately missense-constrained (top ~2.5%)

Observed / Expected Ratios
LoF OE0.12 (0.080.18)
00.351.4
Missense OE0.81 (0.780.85)
00.61.4
Synonymous OE1.10
01.21.6
LoF obs/exp: 19 / 158.6Missense obs/exp: 1404 / 1729.3Syn Z: -2.04
DN
0.3992th %ile
GOF
0.3788th %ile
LOF
0.72top 10%

This gene has evidence for multiple mechanisms of pathogenicity (loss-of-function and gain-of-function). Both the Badonyi & Marsh prediction and the broader genomic evidence point to loss-of-function as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

LOFprediction above median · LOEUF 0.18
GOF1 literature citation

Literature Evidence

GOFThat Hdh inactivation does not mimic adult HD neuropathology suggests that the human disease involves a gain of function.PMID:7618107

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312. Mechanism ranking also informed by gnomAD constraint, ClinVar, and ClinGen data.

ClinVar Variant Classifications

0 submitted variants in ClinVar

Protein Context — Lollipop Plot

HTT · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

3D Protein StructureAlphaFold

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

Postnatal Depression

Home-based Transcranial Direct Current Stimulation in Postpartum Depression: the Feasibility Study and Pilot Study

NOT YET RECRUITING
NCT05046405Phase NAAna Ganho ÁvilaStarted 2022-10-02
Transcranial Direct Current Stimulation
Huntington's Disease

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RG6496 in Huntington's Disease

RECRUITING
NCT07246941Phase PHASE1Hoffmann-La RocheStarted 2025-11-19
RG6496Placebo
Parkinson DiseaseNervous System DisorderNeurodegenerative Diseases

Molecular and Functional Imaging in Monogenic PD.

RECRUITING
NCT05518617University of ExeterStarted 2022-07-01
Positron Emission Tomography (PET) scan using DASB tracer
Huntington Disease

Gene Therapy Development and Validation for Huntington's Disease Fibro TG-HD

RECRUITING
NCT06444217Phase NAUniversity Hospital, AngersStarted 2024-09-23
skin biopsy
Preterm BirthMother-Infant InteractionInfant Development

Continuous Delivery Room Skin-to-skin-study for Moderate and Late Preterm Infants

RECRUITING
NCT05975203Phase NAUniversity of CologneStarted 2023-08-04
skin-to-skin contact
Huntington Disease

A Study to Evaluate AB-1001 Striatal Administration in Adults With Early Manifest Huntington's Disease

ACTIVE NOT RECRUITING
NCT05541627Phase PHASE1, PHASE2Brainvectis, a subsidiary of Asklepios BioPharmaceutical, Inc. (AskBio)Started 2022-10-12
AB-1001 Gene Therapy
Huntington's Disease (HD)

Biology-Driven Cognitive Profiling in Huntington's Disease

ACTIVE NOT RECRUITING
NCT07503743Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant PauStarted 2021-09-01
Parkinson DiseaseParkinson'sParkinson's Disease

Serotonin Release in Premotor and Motor PD

RECRUITING
NCT05516732University of ExeterStarted 2022-07-01
Positron Emission Tomography (PET) scan using CIMBI-36 tracerMagnetic Resonance Imaging (MRI) ScanPositron Emission Tomography (PET) scan using DASB tracer
Subjective Cognitive Decline (SCD)Subjective Cognitive Complaints (SCCs)Subjective Cognitive Impairment

The Signature of Alzheimer's Disease in Subjective Cognitive Decline

RECRUITING
NCT07402161IRCCS Policlinico S. DonatoStarted 2025-10-01
Huntington Disease

Safety and Efficacy of AMT-130 in European Adults With Early Manifest Huntington's Disease

ACTIVE NOT RECRUITING
NCT05243017Phase PHASE1, PHASE2UniQure Biopharma B.V.Started 2021-10-07
intra-striatal rAAV5-miHTT
Huntington Disease

A Randomised Controlled Trial, Of N-Acetyl Cysteine (NAC), for Premanifest Huntingtin Gene Expansion Carriers

RECRUITING
NCT05509153Phase PHASE2Western Sydney Local Health DistrictStarted 2024-06-01
NACPlacebo
Invasive PreNatal Diagnosis in a Context of Family History of Single-gene Disorders, IncludingSickle Cell DiseaseCystic Fibrosis

Development of Non-Invasive Prenatal Diagnosis for Single Gene Disorders

RECRUITING
NCT06147414Assistance Publique - Hôpitaux de ParisStarted 2024-10-23
Blood sample
Clinical Literature
Open Research Assistant →
Key Publications
Landmark & review papers · by relevance
PubMed
Top 5 results · since 2015Search PubMed ↗